| Added by | mollevi |
|---|---|
| Group name | EquipePC |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Department of Biopathology, CHU Montpellier, Montpellier, France; University of Montpellier I, Montpellier, France. University of Montpellier I, Montpellier, France; Department of Dermatology, CHU Montpellier, Montpellier, France; U1058, INSERM, University of Montpellier I, Montpellier, France. Department of Biopathology, CHU Montpellier, Montpellier, France. University of Montpellier I, Montpellier, France; U1058, INSERM, University of Montpellier I, Montpellier, France; Department of Virology, CHU Montpellier, Montpellier, France. Department of Biopathology, CHU Montpellier, Montpellier, France; University of Montpellier I, Montpellier, France; U1058, INSERM, University of Montpellier I, Montpellier, France. Department of Biopathology, CHU Montpellier, Montpellier, France; University of Montpellier I, Montpellier, France; Department of Clinical Oncoproteomics, Montpellier Cancer Institute (ICM), Montpellier, France. alt-title: PloS one number: 10 accession-num: 25360634 |
| Tags | _EndnoteXML import |
| Date Added | 2018/11/14 - 12:07:50 |
| Date Modified | 2018/11/14 - 12:07:50 |
| Parent item | Cutaneous epithelial tumors induced by vemurafenib involve the MAPK and Pi3KCA pathways but not HPV nor HPyV viral infection |
Institut de Recherche en Cancérologie de
